Implantable DBS Electrodes for Targeted Brain Tumor Electrotherapy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cancer treatments, particularly for glioblastoma multiforme (GBM), are invasive and harmful to healthy brain tissue, with limited efficacy due to the invasiveness of tumors and the unique anatomy of the central nervous system, and existing external electrode therapies are limited by the dampening of electric fields through the skull and soft tissue.

Innovation Solution

A DBS system with implantable leads and a signal generator that delivers targeted electromagnetic fields directly to tumors, using customizable electrode configurations and stimulation settings to inhibit tumor cell growth processes, such as mitosis, immune suppression, and DNA replication, and can adjust parameters to counter tumor adaptation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If external electrode therapy is applied to treat GBM, then cancer proliferation is reduced, but the strength of the electric field is dampened due to the skull and soft tissue

Engineering Contradiction:
Improvecancer treatment efficacyVSAvoidelectric field strength
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The patent introduces an intermediary approach by placing electrodes directly on the tumor surface, eliminating the skull and soft tissue as intermediaries that dampen the electric field. This direct placement allows the electric field to reach the tumor cells with full strength without attenuation through bone and tissue layers.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent transitions from external application (outside the skull) to internal application (inside the skull, directly on tumor). This dimensional change from extracranial to intracranial placement eliminates the path length through the skull and soft tissue, restoring electric field strength at the tumor site.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If conventional cancer treatments (surgery, radiotherapy, chemotherapy) are applied, then tumor cells are attacked, but healthy brain tissue is damaged

Engineering Contradiction:
Improvetumor treatment effectivenessVSAvoiddamage to healthy tissue
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by directing the electric field specifically to the tumor location through directly implanted electrodes. The field is localized to the tumor site rather than affecting the entire brain, thereby treating cancer cells while preserving healthy brain tissue from damaging effects.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent substitutes mechanical/invasive treatments (surgery, radiation, chemotherapy) with an electromagnetic field-based approach. The electric field penetrates cells and disrupts their function non-contactedly, avoiding the physical damage and toxicity associated with conventional mechanical and chemical treatments.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

3Strength

If electrodes are placed close to the tumor, then the electric field strength is optimized, but the treatment becomes more invasive

Engineering Contradiction:
Improveelectric field strengthVSAvoidtreatment invasiveness
Core Design Contradiction:
StrengthVSEase of manufacture

Solution Approach 1:

The patent uses the tumor itself as an intermediary guide for electrode placement. By placing electrodes on the tumor surface, the treatment leverages the tumor's own location and characteristics to achieve optimal field strength, rather than requiring deep penetration through healthy tissue.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent employs preliminary imaging and mapping to identify the exact tumor location and characteristics before electrode implantation. This preliminary characterization allows for precise electrode placement that optimizes field strength while minimizing invasiveness by targeting only the tumor site.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The system provides a minimally invasive treatment that is more effective than traditional methods, with reduced collateral damage to healthy tissue, and can adapt to the tumor's rapid adaptation by altering stimulation settings, effectively halting tumor growth.

Implementation Method 1

application of electric fields to the scalp has been used disrupt interactions among charged molecules, which reduces cancer proliferation

Methodology Applied
Scientific EffectElectric field: Electric Field

Implementation Method 2

Recent efforts have suggested that external electrode therapy can improve the prognosis of GBM patients

Methodology Applied
Scientific EffectElectromagnetic radiation: Electromagnetic Induction

Data Source

PatentUS12458800B2Devices and methods for treatment of tumors using electromagnetic signal
Publication Date: 2025.11.04 REGENTS OF THE UNIVERSITY OF MINNESOTA
  • US12458800B2 patent drawing
  • US12458800B2 patent drawing
  • US12458800B2 patent drawing

AI summary

Systems and methods for treating cancerous tumors (including glioblastoma multiforme (GBM)) with electrotherapy, such as deep brain stimulation (DBS) technology, as disclosed herein. One or more configurations can be generated based on a patients tumor characteristics. The selected configurations can be electrode configurations or settings for an electrical source coupled to the electrodes. The one or more configurations can be targeted for inhibiting cell growth process, such as to inhibit mitosis, immune suppression, or to inhibit DNA replication. Inhibition of cell growth processes can initiate death of the cancerous cells.